0001209191-12-008686.txt : 20120209
0001209191-12-008686.hdr.sgml : 20120209
20120209160915
ACCESSION NUMBER: 0001209191-12-008686
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120208
FILED AS OF DATE: 20120209
DATE AS OF CHANGE: 20120209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Lisa
CENTRAL INDEX KEY: 0001349077
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 12587271
MAIL ADDRESS:
STREET 1: 125 SPRING STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2012-02-08
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001349077
Kelly Lisa
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
SVP, Human Resources
Common Stock
2012-02-08
4
S
0
8133
36.80
D
28575
D
Common Stock
1667
I
401(k)
Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $36.80 (range $36.50 to $37.25).
Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
David T. Howton, Attorney-In-Fact
2012-02-09